FGL1 and thyrotoxicosis: This finding offers substantial evidence to support our speculation that decrease in hepassocin levels, accompanied with improvement of thyrotoxicosis in humans and changes in serum hepassocin levels, may be a reactive and compensatory response to thyrotoxicosis.